Search - tctmd.com

Displaying 961 - 980 of 2029

Sort: Relevancy | Date

Presentation

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI

Presenter: K.W. Park

July 07, 2014

News Daily News

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

Presentation

REWARD-MI: Real-World Comparison of the MGuard Stent vs BMS for STEMI

Presenter: Agust?n Fern?ndez-Cisnal

July 02, 2014

Presentation

Stent Thrombosis in New-Generation DES in Patients with STEMI Undergoing Primary PCI in SCAAR

Presenter: Giovanna Sarno

July 01, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Daily News

Un Estudio Pone de Manifiesto la Disparidad entre Resultados de Estudios Pre y Post-Comercialización sobre SLF

Caitlin E. Cox

June 13, 2014

News Daily News

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Caitlin E. Cox

June 13, 2014

Presentation

Usefulness of Postmarket Studies to Evaluate Long-term Safety of Coronary Stents

Presenter: Moshe Vardi

June 11, 2014

Presentation

Trend in the Use of DES in the United States: Insight from Over 8.1 Million Coronary Interventions

Presenter: Sripal Bangalore

June 02, 2014

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Daily News

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

May 30, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

Presentation

Comparison of Biolimus A9-eluting (Nobori) and EES (Promus Element) in Long Coronary Lesions

Presenter: J.Y. Lee

May 29, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

Presentation EuroPCR 2014

Final Five Year Outcomes of the NOBORI2 Trial

Presenter: G.B. Danzi

May 22, 2014

Presentation EuroPCR 2014

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Presenter: Hiroyoshi Yokoi

May 21, 2014

News Conference News EuroPCR 2014

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Caitlin E. Cox

May 21, 2014

Advertisement

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

REWARD-MI: Real-World Comparison of the MGuard Stent vs BMS for STEMI

Stent Thrombosis in New-Generation DES in Patients with STEMI Undergoing Primary PCI in SCAAR

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Un Estudio Pone de Manifiesto la Disparidad entre Resultados de Estudios Pre y Post-Comercialización sobre SLF

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Usefulness of Postmarket Studies to Evaluate Long-term Safety of Coronary Stents

Trend in the Use of DES in the United States: Insight from Over 8.1 Million Coronary Interventions

Nationwide Registry Shows Trends in DES Use Over a Decade

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Comparison of Biolimus A9-eluting (Nobori) and EES (Promus Element) in Long Coronary Lesions

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Final Five Year Outcomes of the NOBORI2 Trial

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content